Ignite Creation Date:
2024-05-06 @ 5:52 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05462054
Status:
WITHDRAWN
Last Update Posted:
2022-10-18
First Post:
2022-07-05
Brief Title:
Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy
Sponsor:
Capsida Biotherapeutics Inc
Organization:
Capsida Biotherapeutics Inc
Study Overview
Official Title:
A Phase 0 Non-interventional Multi-center Natural History Study in Pediatric Patients with Syntaxin Binding Protein 1 STXBP1 Encephalopathy with Epilepsy
Status:
WITHDRAWN
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Withdrawn no patients enrolled
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective non-interventional longitudinal study designed to characterize the natural history of STXBP1 related encephalopathy with epilepsy in participants 5 years of age
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None